LaVoieHealthScience Awarded Best Pharma Product Launch at 2024 PRWeek Healthcare Awards
Business Wire
BOSTON & NEW YORK--(BUSINESS WIRE)--LaVoieHealthScience (LHS) is honored to be awarded with the prestigious title of "Best Pharma..
Epidermal growth factor receptor
News and Video Search Results
News coverage
-
Mersana Therapeutics to Present at Upcoming Investor Conferences
GlobeNewswire
-
Alphamab Oncology Announces the First Patient Dosed in a Phase I Clinical Study of HER3/TROP2 Bispecific ADC Drug JSKN016
PR Newswire Asia
-
FDA Grants Breakthrough Therapy Designation to Genentech’s Inavolisib for Advanced Hormone Receptor-Positive, HER2-Negative Breast Cancer with a PIK3CA Mutation
Business Wire
-
FDA grants Breakthrough Therapy Designation to Roche’s inavolisib for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation
GlobeNewswire
0 shares
1 views
You might like
Epidermal growth factor receptor media coverage
Azitra, Inc. Announces Positive Preclinical Data from ATR-04 Presented at the Society of Investigative Dermatology Annual Meeting
Business Wire
BRANFORD, Conn.--(BUSINESS WIRE)--Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on..
-
CytomX Therapeutics Announces New Employment Inducement Grants
GlobeNewswire
-
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in Combination with Palbociclib (IBRANCE®)
GlobeNewswire
-
Veru Announces Steven B. Heymsfield M.D. as the Principal Investigator for its Enobosarm Phase 2b Clinical Trial for High Quality Weight Loss
GlobeNewswire
-
Olema Oncology Announces Promising New Data for Palazestrant in Combination with Ribociclib Presented at the 2024 ESMO Breast Cancer Congress
GlobeNewswire